C. O'Sullivan, V. Suman, Krishna R. Kalari, A. Moyer, J. Sung, A. Moreno-Aspitia, D. Northfelt, M. Liu, T. Haddad, S. Chumsri, F. Couch, R. Weinshilboum, Liewei Wang, M. Goetz
{"title":"OT3-02-08:接受帕博西尼和内分泌治疗(PROMISE)的晚期或转移性雌激素受体阳性和HER2阴性乳腺癌患者血液、尿液、粪便和肿瘤样本的遗传分析","authors":"C. O'Sullivan, V. Suman, Krishna R. Kalari, A. Moyer, J. Sung, A. Moreno-Aspitia, D. Northfelt, M. Liu, T. Haddad, S. Chumsri, F. Couch, R. Weinshilboum, Liewei Wang, M. Goetz","doi":"10.1158/1538-7445.sabcs18-ot3-02-08","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19476,"journal":{"name":"Ongoing Clinical Trials","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract OT3-02-08: Genetic analysis in blood, urine, stool and tumor samples from patients with advanced or metastatic estrogen receptor positive and HER2 negative breast cancer receiving palbociclib and endocrine therapy (PROMISE)\",\"authors\":\"C. O'Sullivan, V. Suman, Krishna R. Kalari, A. Moyer, J. Sung, A. Moreno-Aspitia, D. Northfelt, M. Liu, T. Haddad, S. Chumsri, F. Couch, R. Weinshilboum, Liewei Wang, M. Goetz\",\"doi\":\"10.1158/1538-7445.sabcs18-ot3-02-08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19476,\"journal\":{\"name\":\"Ongoing Clinical Trials\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ongoing Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.sabcs18-ot3-02-08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ongoing Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.sabcs18-ot3-02-08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract OT3-02-08: Genetic analysis in blood, urine, stool and tumor samples from patients with advanced or metastatic estrogen receptor positive and HER2 negative breast cancer receiving palbociclib and endocrine therapy (PROMISE)